Molecular Templates, Inc.Company Review & Valuation

MTEM
Nasdaq
Latest Price
11.07USD
Market Capitalization
504.67mUSD

About Molecular Templates, Inc.

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other diseases. The company primarily develops a pipeline of engineered toxin bodies. Its lead drug candidate is MT-3724 that is inShow more a Phase I clinical trial for the treatment of relapsed/refractory non-Hodgkin's lymphoma and B-cell lymphoma. The company also develops MT-4019, a preclinical drug candidate targeting CD38; and other candidates that are in pre-clinical development for the treatment of solid and hematological cancers. It has an agreement with Takeda Pharmaceutical Company Limited to develop CD38-targeted engineered toxin bodies for the treatment of patients with diseases, such as multiple myeloma. Molecular Templates, Inc. is headquartered in Austin, Texas.Show less

Industry
Biotechnology
HQ Location
Austin, Texas

Stock Price

Price data not available for Molecular Templates, Inc..

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

Codexis
ACADIA Pharmaceuticals
Trevena
Incyte

back to top